Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines
NCT04412044
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Mepolizumab Injection [Nucala]
Sponsor
KU Leuven